The prevalence of MASH continues to rise, affecting millions globally. Previously studied under NASH, this progressive disease remains a major concern due to its potential to advance to cirrhosis and hepatocellular carcinoma. https://www.delveinsight.com/blog/from-nash-to-mash?utm_source=blog&utm_medium=promotion&utm_campaign=kkpr